Kidney Cancer’s Metabolic Rewiring Exposes New Drug Targets
A review in Genes & Diseases maps how VHL loss drives metabolic reprogramming in clear cell renal cell carcinoma and ...
A review in Genes & Diseases maps how VHL loss drives metabolic reprogramming in clear cell renal cell carcinoma and ...
A new study reveals how the energy sensor AMPK stabilizes the oxygen-responsive protein HIF-2α to drive red blood cell maturation ...
A deep-learning-guided virtual screen identified four molecules that block the HIF-1α/VHL interaction, including the approved myeloma drug ixazomib, which protected ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine